Checkcells, Inc.

Checkcells, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on April 9, 2026 and the most recent on April 9, 2026 (Seaman Pro/Seaman). Its most common review panel is Hematology (1 device).